Evidence map›Paper›PMID 23355946›Full record

ArticleJournal of healthcare engineering2012

Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Dan T Simionescu, Joseph Chen, Michael Jaeggli, Bo Wang, Jun Liao

Abstract read
In one paragraph

Article in Journal of healthcare engineering, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.Journal of cellular and molecular medicine · 2021
    Review
  6. Article
  7. Regenerative medicine · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dan T SimionescuBiocompatibility and Tissue Regeneration Laboratory, Department of Bioengineering, Clemson University, Clemson, SC 29634.
Joseph Chen
Michael Jaeggli
Bo Wang
Jun Liao

Funding

Tissue Engineered Aortic Heart Valves: Scaffolds and Stem CellsR01HL093399 · NHLBI · CLEMSON UNIVERSITY · PI SIMIONESCU, DAN TEODOR · 2010 to 2013
$1.4M
BIOACTIVE SCAFFOLDS FOR VASCULAR SURGERYR21HL084194 · NHLBI · CLEMSON UNIVERSITY · PI SIMIONESCU, DAN TEODOR · 2007 to 2008
$404k
Tissue Engineered Cardiac Patches: Multifaceted Stimulation of Stem Cells in DeceR15HL097321 · NHLBI · MISSISSIPPI STATE UNIVERSITY · PI LIAO, JUN · 2009 to 2009
$205k
NHLBI NIH HHS R01 HL093399NHLBI NIH HHS R15 HL097321NHLBI NIH HHS R21 HL084194
6 · The paper itself

Abstract

Tissue engineering the aortic heart valve is a challenging endeavor because of the particular hemodynamic and biologic conditions present in the native aortic heart valve. The backbone of an ideal valve substitute should be a scaffold that is strong enough to withstand billions of repetitive bending, flexing and stretching cycles, while also being slowly degradable to allow for remodeling. In this review we highlight three overlooked aspects that might influence the long term durability of tissue engineered valves: replication of the native valve trilayered histoarchitecture, duplication of the three-dimensional shape of the valve and cell integration efforts focused on getting the right number and type of cells to the right place within the valve structure and driving them towards homeostatic maintenance of the valve matrix. We propose that the trilayered structure in the native aortic valve that includes a middle spongiosa layer cushioning the motions of the two external fibrous layers should be our template for creation of novel scaffolds with improved mechanical durability. Furthermore, since cells adapt to micro-loads within the valve structure, we believe that interstitial cell remodeling of the valvular matrix will depend on the accurate replication of the structures and loads, resulting in successful regeneration of the valve tissue and extended durability.

Identifiers

PMID23355946
PMCPMC3552623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.